These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Clozapine-induced agranulocytosis: a situation report up to August 1976. Anderman B; Griffith RW Eur J Clin Pharmacol; 1977 Mar; 11(3):199-201. PubMed ID: 852497 [TBL] [Abstract][Full Text] [Related]
14. [The most common complications in neuroleptic therapy. A case report]. Preradović M Vojnosanit Pregl; 1981; 38(3):211-2. PubMed ID: 7281540 [No Abstract] [Full Text] [Related]
15. [Acute bone marrow and liver damage during treatment with clozapine]. Brodowski L; Matusewicz W; Urbańska-Ryś H; Krykowski E Pol Tyg Lek; 1984 May; 39(21):721-2. PubMed ID: 6483677 [No Abstract] [Full Text] [Related]
16. Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies. Claas FH Psychopharmacology (Berl); 1989; 99 Suppl():S113-7. PubMed ID: 2682726 [TBL] [Abstract][Full Text] [Related]
17. FDA's position on the clozaril patient management system. Peck CC Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475 [No Abstract] [Full Text] [Related]
18. Leponex--associated granulocytopenia: a review of the situation. Krupp P; Barnes P Psychopharmacology (Berl); 1989; 99 Suppl():S118-21. PubMed ID: 2682727 [No Abstract] [Full Text] [Related]
19. Notes from a state mental health directors' meeting on clozapine. Salzman C Hosp Community Psychiatry; 1990 Aug; 41(8):838-9, 842. PubMed ID: 2401474 [No Abstract] [Full Text] [Related]
20. Proceedings: The relation between the clinical effect of clozapine and the incidence of side effects. Marecek P; Dolezalová V; Faltus F Act Nerv Super (Praha); 1975; 17(4):221-2. PubMed ID: 1221762 [No Abstract] [Full Text] [Related] [Next] [New Search]